SKI Market

Indian Indices

Sensex

83,294.66 479.95
( 0.58%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Piramal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543635

INE0DK501011

58.2770662

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PPLPHARMA

28.9

21321.14

EPS(TTM)

Face Value()

Div & Yield %

5.55

0.09

Back

tata investment corporation ltd

Nestle India consolidated net profit declines 17.38% in the September 2025 quarter

Oct 16,2025

Net profit of Nestle India declined 17.38% to Rs 743.17 crore in the quarter ended September 2025 as against Rs 899.49 crore during the previous quarter ended September 2024. Sales rose 10.95% to Rs 5630.23 crore in the quarter ended September 2025 as against Rs 5074.76 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5630.23	5074.76	11
OPM %	21.79	22.94	-
PBDT	1181.84	1138.65	4
PBT	1018.49	1017.05	0
NP	743.17	899.49	-17

83,294.66 479.95 ( 0.58%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)